Benitec Biopharma Inc (BNTC)

Cost of Revenue

$124.00K

Quarterly · Period ending: · USD

BNTC logo

BNTC Cost of Revenue

Latest reported$124.00K
BNTC Quarterly Cost of Revenue ($14.42K → $124.00K)
High-resolution chart · PNG

BNTC cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Benitec Biopharma Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
124,000
119,000
120,000
118,000
278,000
106,000
81,000
91,000
15,000
-3,000
1,000
-106,000
84,000
0
41,000
102,000
9,000
0
0
102,000
1,000
7,000
-19,000
134,000
48,000
77,395
-434,463
38,610
42,908
42,261
248,646
259,505
251,786
118,459
82,789
20,931
-14,529
107,580
50,670
12,849
32,308
18,987
48,936
-22,787
46
-1,599
19,037
19,987
94,054
93,893
2,798
2,780
0
0
14,551
14,422
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.